Cancer Genetics

Article	Citations
135. Tumor deconvolution using comprehensive single-cell RNA sequencing cell type signatures	108
13. HPV forms chimeric virus-human transcripts that affect host gene expression in cervical tumors	58
27. Five-year experience of evaluating individuals at-risk for underlying genetic predisposition to hematologic malignancy	40
58. Improving the molecular diagnosis of SBDS-related disorders by identifying rare gene conversion events.	27
116. Integrating methylation profiling into adult brain tumor diagnostics - the Australian experience	23
96. A unique case presentation of pediatric spinal ependymoma with chromothripsis of chromosome 6: case report	19
17. Multi-consortia initiative to standardize the representation and curation of oncogenic fusions	18
49. Clinical validation of Infinium CytoSNP-850K SNP-Array for routine copy number profiling of hematological malignancies	16
The hsa-miR-516a-5p and hsa-miR-516b-5p microRNAs reduce the migration and invasion on T98G glioblastoma cell line	15
26. An ATIC::ALK fusion created by balanced insertion rather than inversion of chromosome 2 in an ALK+ anaplastic large cell lymphoma	15
Whole-exome sequencing in osteosarcoma with distinct prognosis reveals disparate genetic heterogeneity	15
Exploring the role of transcription factor TWIST1 in bladder cancer progression	14
A multimodal genomics approach to diagnostic evaluation of pediatric hematologic malignancies	14
43. Challenges of classifying variants associated with disorders of somatic mosaicism and guideline creation	13
64. A rare finding of triple KRAS mutations with OmniSeq® INSIGHT in a patient with colorectal adenocarcinoma	13
2. Diagnostic next generation sequencing to detect MYD88 L265P in lymphoplasmacytic lymphoma compared to ddPCR	12
40. Prioritization of defining and supportive diagnostic variants in pediatric tumors	12
Molecular determinants of clinical outcomes for anaplastic lymphoma kinase–positive non-small cell lung cancer in Chinese patients: A retrospective study	11
LncRNA FOXD2-AS1 promotes the growth, invasion and migration of OSCC cells by regulating the MiR-185–5p/PLOD1/Akt/mTOR pathway	11
Distinct mechanisms of PTEN inactivation in dogs and humans highlight convergent molecular events that drive cell division in the pathogenesis of osteosarcoma	10
Comprehensive analysis of PLKs expression and prognosis in breast cancer	10
The prognostic significance of FOXC2 gene expression in cancer: A comprehensive analysis of RNA-seq data from the cancer genome atlas	10
6. Optical genome mapping as a potential Tier1 test for Postnatal Chromosomal Disorders – results of multi-institutional validation study of 331 retrospective clinical samples	9
13. Remember breakpoint two: Enhancer swapping, a frequent deleterious consequence of balanced chromosomal rearrangements	9
A rare CALR variant mutation and efficient peginterferon alfa-2a response in a patient with essential thrombocythemia	8

74. Genetic and functional characterization of complex chromosomal rearrangements in a family with multisystem anomalies	8
31. Rare familial rearrangement with acrocentric satellite material on Yp relocating to Xp in a female fetus	8
61. Clinical whole exome/whole transcriptome analysis detects clinically relevant structural alterations in Multiple Myeloma	8
28. Trisomy 21 silencing in hematopoietic and neural cells: New insights and prospects	8
8. Harnessing the power of microarray in the analysis of rarer pediatric sarcomas	7
3. Application of optical genome mapping to identify samples with homologous recombination deficiency	7
14. Concurrent systemic mastocytosis and T-lymphoblastic lymphoma unified by a novel cryptic JAKMIP2::PDGFRB rearrangement	7
36. Significant copy number variants and loss of heterozygosity in Wilms Tumor: Insights from Nationwide Pediatric Oncology	7
17. Deconvolution of genetic heterogeneity in Glioblastoma using multi-region sampling	7
16. International working group recommendations for the implementation of optical genome mapping in Hematologic Malignancies	7
102. Using cytogenomics to distinguish two types of renal cell carcinoma in a composite or collision tumor	7
129. Standardization of cancer terminology in the Mondo Disease Ontology	7
99. Histopathologic Correlation Somatic Variants in Non Small Cell Lung Cancer with High Tumor Mutation Burden	7
104. A hematologic case with germline deletion of PMS2 and increased risk of HNPCC studied by optical genome mapping and NGS	7
4. Comprehensive next generation cytogenomics improves risk stratification of acute myeloid leukemia	7
15. Clinical impact of in-house molecular testing for underserved cancer patients in southern Alabama	7
22. Cell-free DNA genomic and epigenomic analysis to predict survival in mCRPC patients treated with AR-directed therapy	6
Clinical management of TP53 mosaic variants found on germline genetic testing	6
Identification of a novel stemness-related signature with appealing implications in discriminating the prognosis and therapy responses for prostate cancer	6
56. Variants of established clinical significance: Progress and challenges in the VECS SC-VCEP	6
Exosomal DNMT1 mRNA transcript is elevated in acute lymphoblastic leukemia which might reprograms leukemia progression	6
Cryptic KMT2A/MLLT10 fusion detected by next-generation sequencing in a case of pediatric acute megakaryoblastic leukemia	6
70. Acute myeloid leukemia with a novel AKAP9::PDGFRA fusion transformed from essential thrombocythemia	6
Three FGFR4 gene polymorphisms contribute to the susceptibility of urethral cancer in the middle and south of Iraq population	6
Study on the use of Nanostring nCounter to analyze RNA extracted from formalin-fixed-paraffin-embedded and fresh frozen bladder cancer tissues	6
Methylation signatures as biomarkers for non-invasive early detection of breast cancer: A systematic review of the literature	6
Double heterozygous pathogenic variants in the BRCA1 and BRCA2 genes in a patient with bilateral metachronous breast cancer	6
Analysis of polymorphisms in EGF, EGFR and HER2 genes in pancreatic neuroendocrine tumors (PNETs)	6
53. Uveal melanoma - The New Zealand perspective	5
32. Clinical utility and feasibility of adopting optical genome mapping for chromosomal characterization of solid tumors	5
76. Goals, methods and challenges in a clinical validation of a NGS-based platform for the detection of constitutional CNVs	5
18. Cell-free DNA 5-hydroxymethylcytosine is an emerging marker of acute myeloid leukemia	5
Is 5q deletion in de novo Acute Myelogenous Leukemia (AML) with excess blasts a surrogate marker for the cryptic t(7;21)(p22;q22)? A case report and review of literature	5
Distinct somatic DICER1 hotspot mutations in three metachronous ovarian Sertoli-Leydig cell tumors in a patient with DICER1 syndrome	5
44. Clinical utility of pharmacogenomics testing with an expanded panel	5
79. Implications of fortuitous detection of JAK2 V617F mutations with solid tumor clinical sequencing	5
37. Epigenetic reprogramming of brain development pathways during non-small cell lung cancer metastasis to brain	5
Prognosis prediction and drug guidance of ovarian serous cystadenocarcinoma through mitochondria gene-based model	5
14. Four-way translocation in a patient with mild clitoromegaly	5
50. Chromosomal microarray uncovers novel mechanisms of progression in myelodysplastic syndromes with normal karyotype	5
139. Feasibility of comprehensive whole genome profiling in hematological malignancies	5
63. Comparative analysis of testing methods used for the detection of internal tandem duplications in the KMT2A/MLL gene	5
7. Overview of recurrent and novel gene fusions detected in a clinical diagnostic laboratory	5
TERT gene rearrangement in chordomas and comparison to other TERT-rearranged solid tumors	4
TCGA dataset screening for genes implicated in endometrial cancer using RNA-seq profiling	4
Identification of BRIP1, NSMCE2, ANAPC7, RAD18 and TTL from chromosome segregation gene set associated with hepatocellular carcinoma	4
A complex t(15;22;17)(q22;q11.2;q21) variant of APL	4
9. Best practices for testing and reporting of FISH studies in multiple myeloma: Recommendations from the CGC working group	4
26. Co-occurrence of rosette-forming glioneuronal tumors with Noonan Syndrome	4
16. Uniparental disomy (UPD) of multiple chromosomes in two cases with a complex phenotype	4

31. A cross-consortia initiative for aligning the definitions and descriptions of gene fusions	4
Rare and potentially fatal ‐ Cytogenetically cryptic TNIP1::PDGFRB and PCM1::FGFR1 fusion leading to myeloid/lymphoid neoplasms with eosinophilia in children	4
60. AI-guided histopathology predicts brain metastasis in lung cancer patients	4
Molecular follow-up of first-line treatment by osimertinib in lung cancer: Importance of using appropriate tools for detecting EGFR resistance mutation C797S	4
2. Clinical, cytogenetic and genomic profiling of B-Other Acute Lymphoblastic Leukemia: An Indian cohort study	4
120. Expert curation of FLT3 variants by the ClinGen FLT3 Somatic Cancer Variant Curation expert panel	4
77. dic(7;9):A distinct entity in B-ALL with multiple genomic aberrations including IKAROS and PAX5	4
24. Tissue-based sequencing for laboratory diagnosis of Somatic Mosaic Disorders	4
66. Optical genome mapping workflow for Somatic Abnormality detection in Multiple Solid Tumor types	4
38. Formation of a tumor-specific gene list: The Central Nervous System (CNS) tumor taskforce experience	4
Myeloid/Lymphoid Neoplasm with FGFR1 Rearrangement Presenting with Polycythemia Vera and T-cell Acute Lymphoblastic Leukemia.	4
A rare case of atypical chronic myeloid leukemia associated with t(8;22)(p11.2;q11.2)/ BCR-FGFR1 rearrangement: A case report and literature review	3
24. Clinical utility of optical genome mapping: comparison with standard cytogenomics work-up for hematological malignancies	3
7. AI-Based Algorithms for neoplastic metaphase cells boost efficiencies in the cytogenetics laboratory	3
22. Reducing diagnostic FISH turn-around-time: A rapid pipeline for BCR::ABL1 and PML::RARA suspected leukemias	3
12. The landscape of structural variation discovery and interpretation across global populations and the developmental continuum	3
65. Insights into the genetic heterogeneity of glioblastoma: gene amplification in ecDNA and HSR	3
Lynch syndrome caused by a novel deletion of the promoter and exons 1–13 of MLH1 gene	3
7. Optical genome mapping for prenatal diagnostic testing	3
56. Optical genome mapping reveals genomic complexity and detects novel genetic abnormalities in T-Lymphoblastic Leukemia	3
Necessity of multiplex ligation probe amplification in genetic tests: Germline variant analysis of the APC gene in familial adenomatous polyposis patients	3
127. Characterization of alternative transcription start and termination sites in glioblastoma	3
Editorial Board	3
21. Translating human readable variation descriptions to unique computable variations with the Variation Normalizer	3
93. Surveying the genomic landscape of Mantle Cell Lymphoma	3
24. Donor-derived acute myeloid leukemia in a recipient of liver-transplantation	3
45. Clonal hematopoiesis in childhood cancer survivors	3
Hypomethylation of DRD2 promotes breast cancer through the FLNA-ERK pathway	3
A comparison of WHO-5 and ICC classifications in a series of myeloid neoplasms, considerations for hematopathologists and molecular pathologists	3
57. A rare case of near-tetraploidy in CLL: An investigation by MLPA, FISH, and chromosome analysis	3
Genotype-cancer association in patients with Fanconi anemia due to pathogenic variants in FANCD1 (BRCA2) or FANCN (PALB2)	3
94. Initial efforts of the ClinGen Solid Tumor Taskforce in promoting variant curation in solid tumors into CIViC	3
Editorial Board	3
9. The dual PI3K inhibitor duvelisib potently inhibits cytokine release syndrome while maintaining CAR-T function	3
98. A bioinformatics analysis of differentially expressed genes in non-small cell lung cancer subtypes	3
18. Trisomy 18p detected in DNA from saliva but absent in DNA from blood	3
30. Semi-automated approaches for digital pathology analyses standardize pathologic assessment of clinical melanoma biopsies	3
Editorial Board	3
4. Glioblastomas with MAPK pathway alterations show low grade histologic features and present novel therapeutic targets	3
77. Mining COSMIC for frameshift neoantigens as `off-the-shelf' therapeutic cancer vaccine candidates	3
48. Targeted RNA-Seq on fresh frozen and methanol/acetic acid fixed cells in diagnostic workup of hematologic malignancies	2
79. Extraction of multiple analytes in liquid biopsy may improve the diagnosis of breast cancer	2
46. Integrative cytogenetic and molecular studies unmasks `chromosomal mimicry' in hematologic malignancies	2
43. Association between Clonal Hematopoiesis and Inherited Cancer Susceptibility Genes	2
Dynamics of cell-free DNA in predicting response in adult diffuse glioma on chemoradiotherapy	2
74. Dilemma of selecting the optimal diagnostic test(s) for genetic biomarkers in hematologic malignancies	2
Mast cell leukemia with novel BRAF variant and concomitant atypical KIT variant	2
Editorial Board	2
PTEN alterations in sporadic and BRCA1-associated triple negative breast carcinomas	2
BCR-ABL1 positive AML or CML in blast crisis? A pediatric case report with inv(3) and t(9;22) in the initial clone	2
Metabolic–related gene signatures for survival prediction and immune cell subtypes associated with prognosis in intrahepatic cholangiocarcinoma	2
134. Novel fusions in aggressive infant sarcomas: Expanding the scope of 'CIC-rearranged' sarcoma without CIC rearrangement	2
Mutations of ARID1B, PIK3C2B, KMT2B, and FAT1 genes influence clinical outcome in newly diagnosed myeloma	2
66. Screening for genetic predisposition to pediatric leukemia in a Peruvian population	2
38. Assessment of TRG and TRB clonality by NGS of dermatologic specimens is impacted by biopsy type, DNA and amplicon sizes	2
Differences in the mitochondrial microsatellite instability of Keratoacanthoma and cutaneous squamous cell carcinoma	2
Dysregulation of metallothionein MT1 sub-types in TCF3::PBX1 pre-B-cell acute lymphoblastic leukemia	2
89. TCF3::ZNF384 in a Peruvian girl with mixed-phenotype acute leukemia and poor treatment outcome	2
Mechanistic Study of Liquiritigenin Inhibiting Bladder Cancer Cell Proliferation and Migration by Regulating STING1	2
34. A molecular and clinicopathologic analysis of primary intracranial sarcomas	2
Mesothelin CAR‐T cells secreting PD‐L1 blocking scFv for pancreatic cancer treatment	2
The oncogenic roles of NTRK fusions and methods of molecular diagnosis	2
In silico protein structural analysis of PRMT5 and RUVBL1 mutations arising in human cancers	2
Aggressive systemic mastocytosis with the co-occurrence of PRKG2::PDGFRB, KAT6A::NCOA2, and RXRA::NOTCH1 fusion transcripts and a heterozygous RUNX1 frameshift mutation	2
83. Cytogenetic and molecular characterization of IDH-mutant adult-type diffuse gliomas with near-total 1p/19q co-deletions	2
55. Clinical validation and implementation of exome, transcriptome and whole genome sequencing for pediatric cancers	2
103. Formation of a ClinGen Variant Curation Expert Panel (VCEP) dedicated to Oncohistone H3 Variants in Pediatric Gliomas	2
68. Orthogonal approaches to validate a knowledgebase of interpretations of clinically relevant somatic cancer variants	2
24. Methylation sequencing enhances interpretation of clonal hematopoiesis dynamics	2
Prognostic significance of CCND1 amplification/overexpression in smoking patients with esophageal squamous cell carcinoma	2
Jumping translocation involving chromosome 13q in a patient with Crohn's Disease and inv(16)(p13.1q22)/CBFB-MYH11 acute myeloid leukemia	2
20. Diagnostic utility and lessons learned from deep sequencing vascular malformations	2
78. Next generation cytogenomics improves patient risk stratification in acute myeloid leukemia	2
75. Clinical implementation of a precision medicine consultation service	2
28. Analytical validation of an optical genome mapping assay for structural variant detection in hematologic malignancies	2
Evaluation of DNA methylation in promoter regions of hTERT, TWIST1, VIM and NID2 genes in Moroccan bladder cancer patients	1
9. Optical genome mapping workflow for identification and annotation of variants in hematological malignancy	1
138. Optical Genome Mapping workflow for identification and analysis of variants in Hematological Malignancies	1
91. Atypical BCR::ABL1 rearrangements identified by optical genome mapping in patients with chronic myeloid leukemia	1
81. Discrepancies in the detection of PML::RARA gene rearrangement by FISH using commonly used dual-color dual-fusion probes	1

107. MyVariant.info: a gateway to integrated resource of variant annotations	1
24. Archer system copy number alteration caller: User experience	1
82. Can mitochondrial DNA mutations be used as a biomarker for endometrial cancer?	1
94. Comparison of FISH to whole exome/whole transcriptome detection of relevant structural alterations in Multiple Myeloma	1
65. Creating a common language for categorical variants	1
SP1-induced circ_0017552 modulates colon cancer cell proliferation and apoptosis via up-regulation of NET1	1
Molecular profiling of osteosarcoma in children and adolescents from different age groups using a next-generation sequencing panel	1
63. A female-specific chimeric RNA with differential expression in COVID patients	1
41. Participant reflections from the program for evaluation of Ashkenazi Jewish Cancer heritability involving the BRCA genes	1
131. Clonal Hematopoiesis is associated with risk of Cardiovascular Disease in individuals with Human Immunodeficiency Virus	1
Editorial Board	1
16. ClinGen Cancer Variant Interpretation (CVI) Committee: Pilot guidance for somatic cancer variant curation expert panels	1
12. Contextualizing clinical significance using FDA label supplemented DGI data	1
6. Emerging clinically-relevant applications of ultra-sensitive mutation detection	1
53. Clinical whole exome/whole transcriptome (WES/WTS) analysis detects copy number and structural rearrangements important	1
128. Clinical testing of mismatch repair in neoplasms using multiple laboratory methods	1
130. The Myeloid Malignancy Variant Curation Expert Panel: Investigating RUNX1, GATA2, and DDX41	1
When cascade testing for familial variant seems inadequate to provide clinically actionable information for blood relatives	1
Long-read nanopore sequencing enables accurate confirmation of a recurrent PMS2 insertion–deletion variant located in a region of complex genomic architecture	1
36. Clinical utility of copy number alteration analysis in the evaluation of Melanocytic Lesions for diagnosis and prognosis	1
Prelims	1
The promise of TRK inhibitors in pediatric cancers with NTRK fusions	1
4. Current applications of cell-free DNA in pregnancy and oncology	1
Half of most frequently mutated genes in breast cancer are expressed differentially between premenopausal and postmenopausal breast cancer patients	1
1. Enrichment of Hodgkin and Reed-Sternberg (HRS) cells using size-based microfiltration	1
Multi-region sequencing reveals genetic correlation between esophageal squamous cell carcinoma and matched cell-free DNA	1
43. Fusion Curation Interface: an educational tool to explore a unified framework for representing & curating gene fusions	1
The prognostic, diagnostic, and therapeutic impact of Long noncoding RNAs in gastric cancer	1
53. Microarray-based 'rescue' of failed karyotype testing	1
Expression and potential immune involvement of cuproptosis in kidney renal clear cell carcinoma	1
100. Ultrasensitive molecular residue disease detection enabled by genome wide concatemer error correction	1
62. Characterization of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) with KMT2A amplification	1
23. Complementarity of RNA sequencing and optical genome mapping in detection of rare fusions in pediatric B-ALL	1
BRCA1 and BRCA2 whole cDNA analysis in unsolved hereditary breast/ovarian cancer patients	1
85. Microfilter enrichment of Hodgkin and Reed-Sternberg (HRS) cells	1
90. TERT promoter mutation detection by ddPCR in glial atypia	1
38. Oncogenic evidence in the CIViC data model	1
42. MDM2 and centromere 12 co-amplification presents diagnostic challenge in low grade adipocytic tumors	1
8. Optical genome mapping analysis of FMR1 expansions in fragile X syndrome	1
50. Molecular profiling of Cytolyt-Fixed FNA washes to improve diagnostic yield in lung cancer	1
11. Evaluation of Hi-C versus optical genome mapping for diagnosing constitutional genomic structural variants	1
59. Constellation of rare genetic abnormalities associated with MECOM rearrangement in AML	1
Potential use of SCAT1, SCAT2, and SCAT8 as diagnostic and prognosis markers in colorectal cancer	1
41. Step 2 updates for the oncogenic assessment of FLT3 variants by the ClinGen FLT3 somatic cancer variant curation expert	1
A new four-way complex translocation variant involving the t(8;5;21;4)(q21;q13;q22;q31) and the relocalization of AML1/ETO fusion gene	1
133. Incidental finding of the 1st degree of parental relatedness in a newborn with JBS and homozygous UBR1 mutation	1
20. Comparative analysis of RNA expression identifies druggable targets in difficult-to-treat pediatric solid tumors	1
3. Optical genome mapping reveals novel structural variants in pediatric high grade gliomas	1
83. Quantum lattices for early cancer detection through machine learning	1
9. ETV6-PDGFRA fusions detected by FISH in acute myeloid leukemia with translocation t(4;12)(q12;p13) are false-positive	0
88. Clinical impact of targeted genomic profiling	0
27. Somatic genomic testing and variant curation practices in Australian and New Zealand diagnostic testing laboratories	0
Somatic homozygous loss of SH2B3, and a non-Robertsonian translocation t(15;21)(q25.3;q22.1) with NTRK3 rearrangement, in an adolescent with progenitor B-cell acute lymphoblastic leukemia with the iAM	0
111. pVACsplice: Predicting neoantigens from tumor-specific alternative splicing events derived from regulatory mutations	0
42. Optical genome mapping and 523-gene sequencing panel for comprehensive genomic evaluation of myeloid cancers	0
50. TAGVar: A simple, free software tool to annotate genomic variants for clinical review	0
Molecular subtyping and immune score system by a novel pyroptosis-based gene signature precisely predict immune infiltrating, survival and response to immune-checkpoint blockade in breast cancer	0
29. Tools for functional genomics dataset visualization and analysis	0
Influence of germline test results on surgical decision making in women with invasive breast cancer	0
A t(4;13)(q21;q14) translocation in B-cell chronic lymphocytic leukemia causing concomitant homozygous DLEU2/miR15a/miR16-1 and heterozygous ARHGAP24 deletions	0
t(10;12)(q24;q15): A new cytogenetic marker in hematological malignancies	0
59. Oncogenic assessment of FLT3 variants by the ClinGen FLT3 Somatic Cancer Variant Curation Expert Panel	0
Identification of variant APL translocations PRKAR1A-RARα and ZBTB16-RARα (PLZF-RARα) through the MI-ONCOSEQ platform	0
Novel genomic signature predictive of response to immune checkpoint blockade: A pan-cancer analysis from project Genomics Evidence Neo-plasia Information Exchange (GENIE)	0
71. Integrated genomic analysis of hepatocellular carcinoma using WES and aCGH	0
35. Atypical FISH patterns clarified by RNAseq in solid tumor specimens	0
A new dual translocation of chromosome 14 in a pediatric Burkitt lymphoma/leukemia patient: t(8;14) and t(14;15)	0
35. Integrated comprehensive genomic profiling of meningiomas: A single institutional study	0
4. Integrated genetic risk assessment in De-novo Acute Myeloid Leukemia in children and young adults	0
64. FAIR sharing of cancer GWAS data via the NHGRI-EBI GWAS catalog	0
Association between XRCC3 Thr241Met polymorphism and risk of gynecological malignancies: A meta-analysis	0
Identification and characterization of ADAR1 mutations and changes in gene expression in human cancers	0
Genetic profiling of metastatic colon adenocarcinoma in Iranian patients: Insights into pathogenic variants and tumor characteristics	0
57. Identification of key molecular mechanisms in IDH-mutant brain tumors to enable precise risk stratification	0
Genetic profile in primary tumor tissue of advanced lung adenocarcinoma patients with adrenal metastasis	0
95. Genomic profiling of a t(14;19) small B-cell lymphoma using whole exome sequencing	0
31. Computer-aided cytogenomic classification of renal cell carcinoma	0
70. Epigenetic reprogramming in thalamic H3K27-altered glioma neural progenitor cells	0
29. Increased micronuclei frequency and DNA methylation patterns associated with Down syndrome regression disorder	0
A founder CHEK2 pathogenic variant in association with kidney cancer	0
37. Cell-type-specific genetic-to-epigenetic relationships in the human breast	0
25. Genetic spectrum of RAS Alterations-A Highlight of in-frame insertion variants in association with vascular anomalies	0
67. An undiagnosed chronic myeloid leukemia (CML) with p190 BCR::ABL1 transcript, an extra Philadelphia chromosome, and IKARO	0
1. Clinicopathologic analysis of gliomas harboring ROS1 gene arrangements	0
13. Implementation of new ClinGen/CGC/VICC recommendations for classification of oncogenicity of somatic variants using AI	0
32. pVACsplice: A Computational tool for predicting and prioritizing alternative splicing neoantigens	0
A novel missense mutation in the folliculin gene associated with the renal tumor-only phenotype of Birt-Hogg-Dubé syndrome	0
Neurotrophic tyrosine receptor kinase fusion in pediatric central nervous system tumors	0
2. Personalized sequencing assays for cerebrospinal fluid liquid biopsies in children with brain tumors	0
65. AR/enhancer alterations in metastatic castrate-resistant prostate cancer patient plasma predicts worse overall survival	0
10. SNP microarray analysis of over 7,500 myeloid patients: Implications, importance and suggestions for standard of care	0
99. Donor-derived follicular lymphoma after kidney transplantation - a case report	0
15. Standard procedure for the curation and maintenance of cancer-specific gene lists	0
69. Efficient clinical review of complex NGS tumor copy number profiles using ACMG/CGC guidelines and an interactive web app	0
72. Comprehensive genomic profiling in the diagnosis of Central Nervous System tumors	0